Latest Conference Articles

Harold J. Brody, MD, provides his best tips and tricks for superficial and medium depth chemical peels in a presentation at the 2022 ASDS Annual Meeting.

Immune checkpoint inhibitor therapy does not appear to increase complication rates in patients undergoing dermatologic procedures, according to a video oral abstract presentation at the 2022 ASDS Annual Meeting.

The legacy of the late Vic Narurkar, MD, and his commitment to aesthetics was honored at the 2022 Annual ASDS Meeting.

At the 2022 Annual ASDS Meeting, Mona Gohara, MD, highlights the importance of diversity, equity, and inclusion in the field of dermatology.

Pearl Grimes, MD, FAAD, dives deep into chemical peels, especially for your skin of color patients, at the 2022 ASDS Annual Meeting.

At the Melanoma Update of the Annual ASDS Meeting, Tyler Hollmig, MD, looked at complex clinical scenarios when treating melanoma and the continued challenges dermatologists face.

Sherrif Ibrahim, MD, PhD, provides key pearls from his co-directed session at the 2022 Annual ASDS Meeting, “Defining ‘High-Risk’ for Squamous Cell Carcinoma: Implications for Treatment Paradigms.”

Kimberly Ken, MD, assistant professor of dermatology at Penn State University, discussed crucial methods for advanced melanoma management.

There are multiple factors predicting itch-specific quality of life in patients with chronic itch, according to a video oral abstract presentation at the 2022 ASDS Annual Meeting.

Patricia Farris, MD, dermatologist from Metairie, Louisiana, discusses key pearls from her presentation at the American Society for Dermatologic Surgery (ASDS) Meeting.

Authors of an oral abstract at the 2022 ASDS Annual Meeting presented their findings on the demographics of who requests total body skin exams to screen for skin cancer.

As the American Society for Dermatologic Surgery (ASDS) Annual Meeting begins today, Sue Ellen Cox, MD, president of ASDS, participated in a Q&A session.

Patricia Farris, MD, dermatologist from Metairie, Louisiana, discusses why the American Society for Dermatologic Surgery (ASDS) Annual Meeting is one of her favorite conferences to attend.

The 2022 American Society for Dermatologic Surgery (ASDS) Annual Meeting officially begins today in Denver, Colorado, and continues through October 10th.

SUNSHINE and SUNRISE trials showed superior efficacy over the placebo.

At the 2022 Skin of Color Update meeting in New York City, Saakshi Khattri, MD, talks about the benefits of treating patients who have psoriasis with roflumilast cream.

Taking a deep dive into alopecia areata allows for a better understanding of the cells that are responsible for disease development.

At the Skin of Color Update meeting in New York City, Mona Shahriari, MD, FAAD, shares her thoughts on prescribing the recently-approved tapinarof (VTAMA) for plaque psoriasis.

At a poster session at the Skin of Color Update meeting in New York City, a study looked at whether women of color thought they were well-represented when it comes to learning about skin aging and prevention.

At the Skin of Color Update 2022 meeting, Pearl Grimes, MD, shares her thoughts on the recent approval of ruxolitinib cream.

Medical experts use common set of criteria to diagnose disease.

Study data was presented at EADV 2022 regarding socioeconomic status related to HS.

Hilary Baldwin, MD, discusses what's new and exciting at the Skin of Color Update Meeting in NYC

The relationship between transplant patients and basal cell carcinoma was discussed at EADV Congress 2022 in Milan, Italy.

TMB-001 showed positive results in the reduction of congenital ichthyosis severity in a phase 2b CONTROL study.

New sticky tape study can help predict onset of pediatric atopic eczema in babies.

Arcutis to present data from topical roflumilast clinical program at EADV 2022 Congress.

Abstracts will include updates on treatment for psoriatic arthritis, psoriasis, atopic dermatitis, and more.